The course enables attendees to apply the theory learnt in the taught sessions, and also to directly observe the effect of formulation on product properties, and relate the theory to the practice of ...
LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...
In this free webinar, gain an overview of common formulation challenges in global pharmaceutical development, particularly for APIs with poor solubility and varying physicochemical properties.
To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...
In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...
WILMINGTON, N.C. & BEND, Ore., Oct 26, 2010 (BUSINESS WIRE) -- PPD, Inc. and Bend Research, Inc. today announced they have entered into a collaboration in the areas of formulation development, ...
The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Formulation Development ...
eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...
CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...
Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results